Trial intelligence / Profile preview

Prehospital Antibiotics for Severe Sepsis

ACTRN12618000199213Phase 2Terminated

Sponsor
Ambulance Victoria
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of ceftriaxone in sepsis, sponsored by Ambulance Victoria. Started Jul 2019; status: terminated.

02

Drugs

ceftriaxone
03

Conditions

sepsis

Beyond the preview

Go deeper on ACTRN12618000199213.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12618000199213.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call